Trial results for an observational study investigating telemedicine and connected objects in breast cancer patients were posted on ClinicalTrials.gov on 2025-12-10. The study reported a median quality of life score of 59 at 12 months for patients with advanced disease.
Background
Breast cancer remains a significant health challenge, and for patients with metastatic disease, managing care and maintaining quality of life can be particularly complex, especially for those living far from specialized cancer centers. Telemedicine and connected health technologies offer potential solutions to bridge geographical gaps and provide continuous monitoring and support. This observational study aimed to evaluate the efficiency of such new technologies, including telemedicine and connected objects, in supporting patients with metastatic breast cancer.
Trial design
This was an observational study, titled "Evaluation of Efficiency in Cancerology of New Technologies as Telemedicine and Conected Objects (e-DomSanté)". It enrolled 15 participants with Breast Cancer. The study focused on patients treated for metastatic breast cancer who resided far from their comprehensive cancer center and were followed using telemedicine, connected watches, and patient-reported symptom monitoring.
Key results
The study reported on the quality of life for patients with advanced disease at two time points:
- Quality of Life of the Patients at 6 Months: The median score was 58 on a scale.
- Quality of Life of the Patients at 12 Months: The median score was 59 on a scale.
These measurements indicate the quality of life scores for the group of patients with advanced disease participating in the study.
What this means
For the small cohort of 15 patients with advanced breast cancer followed via telemedicine and connected devices, the median quality of life scores remained stable, showing 58 at 6 months and 59 at 12 months. This suggests that these technological approaches may help maintain patient quality of life over time, particularly for those with metastatic disease living remotely from their care centers. Further research with larger cohorts could explore these trends in more detail.
Source
The information for these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for the study NCT03359759, titled "Evaluation of Efficiency in Cancerology of New Technologies as Telemedicine and Conected Objects (e-DomSanté)", were posted on 2025-12-10 on clinicaltrials.gov.